Failed drug discovery in psychiatry: time for human genome-guided solutions

Insel, 2012, Next-generation treatments for mental disorders, Sci. Transl. Med., 4, 155ps119, 10.1126/scitranslmed.3004873 Hyman, 2012, Revolution stalled, Sci. Transl. Med., 4, 155cm111, 10.1126/scitranslmed.3003142 Abbott, 2011, Novartis to shut brain research facility, Nature, 480, 161, 10.1038/480161a Lander, 2011, Initial impact of the sequencing of the human genome, Nature, 470, 187, 10.1038/nature09792 Collins, 2011, Reengineering translational science: the time is right, Sci. Transl. Med., 3, 90cm17, 10.1126/scitranslmed.3002747 Healy, 2004, Population genetics for target identification, Drug Discov. Today Technol., 1, 69, 10.1016/j.ddtec.2004.08.012 Muglia, 2011, From genes to therapeutic targets for psychiatric disorders – what to expect?, Curr. Opin. Pharmacol., 11, 563, 10.1016/j.coph.2011.08.003 Rasetti, 2011, Intermediate phenotypes in psychiatric disorders, Curr. Opin. Genet. Dev., 21, 340, 10.1016/j.gde.2011.02.003 Plenge, 2013, Validating therapeutic targets through human genetics, Nat. Rev. Drug Discov., 12, 581, 10.1038/nrd4051 Schubert, 2014, Translating human genetics into novel treatment targets for schizophrenia, Neuron, 84, 537, 10.1016/j.neuron.2014.10.037 Sanseau, 2012, Use of genome-wide association studies for drug repositioning, Nat. Biotechnol., 30, 317, 10.1038/nbt.2151 Papassotiropoulos, 2013, Human genome-guided identification of memory-modulating drugs, Proc. Natl. Acad. Sci. U.S.A., 110, E4369, 10.1073/pnas.1314478110 Gustavsson, 2011, Cost of disorders of the brain in Europe 2010, Eur. Neuropsychopharmacol., 21, 718, 10.1016/j.euroneuro.2011.08.008 Smith, 2011, Trillion-dollar brain drain, Nature, 478, 15, 10.1038/478015a Editorial, 2013, Of men, not mice, Nat. Med., 19, 379, 10.1038/nm.3163 Seok, 2013, Genomic responses in mouse models poorly mimic human inflammatory diseases, Proc. Natl. Acad. Sci. U.S.A., 110, 3507, 10.1073/pnas.1222878110 Editorial, 2011, Best is yet to come, Nature, 470, 140, 10.1038/470140a 2014, Biological insights from 108 schizophrenia-associated genetic loci, Nature, 511, 421, 10.1038/nature13595 Sklar, 2011, Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4, Nat. Genet., 43, 977, 10.1038/ng.943 Wang, 2009, Common genetic variants on 5p14.1 associate with autism spectrum disorders, Nature, 459, 528, 10.1038/nature07999 2013, Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis, Lancet, 381, 1371, 10.1016/S0140-6736(12)62129-1 2013 McPartland, 2012, Sensitivity and specificity of proposed DSM-5 diagnostic criteria for autism spectrum disorder, J. Am. Acad. Child Adolesc. Psychiatry, 51, 368, 10.1016/j.jaac.2012.01.007 Kendler, 1998, Boundaries of major depression: an evaluation of DSM-IV criteria, Am. J. Psychiatry, 155, 172, 10.1176/ajp.155.2.172 Zammit, 2013, Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study, Am. J. Psychiatry, 170, 742, 10.1176/appi.ajp.2013.12060768 Whittington, 1996, Changes in the prevalence of psychiatric disorder in a community are related to changes in the mean level of psychiatric symptoms, Psychol. Med., 26, 1253, 10.1017/S0033291700035972 van Os, 2013, The dynamics of subthreshold psychopathology: implications for diagnosis and treatment, Am. J. Psychiatry, 170, 695, 10.1176/appi.ajp.2013.13040474 Lundstrom, 2012, Autism spectrum disorders and autistic like traits: similar etiology in the extreme end and the normal variation, Arch. Gen. Psychiatry, 69, 46, 10.1001/archgenpsychiatry.2011.144 Anderson, 1993, Normality, deviance and minor psychiatric morbidity in the community. A population-based approach to General Health Questionnaire data in the Health and Lifestyle Survey, Psychol. Med., 23, 475, 10.1017/S0033291700028567 Toulopoulou, 2007, Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples, Arch. Gen. Psychiatry, 64, 1348, 10.1001/archpsyc.64.12.1348 Quee, 2014, Cognitive subtypes in non-affected siblings of schizophrenia patients: characteristics and profile congruency with affected family members, Psychol. Med., 44, 395, 10.1017/S0033291713000809 David, 2010, Why we need more debate on whether psychotic symptoms lie on a continuum with normality, Psychol. Med., 40, 1935, 10.1017/S0033291710000188 Weinberger, 2014, RDoCs redux, World Psychiatry, 13, 36, 10.1002/wps.20096 Gottesman, 2003, The endophenotype concept in psychiatry: etymology and strategic intentions, Am. J. Psychiatry, 160, 636, 10.1176/appi.ajp.160.4.636 Egan, 2004, Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia, Proc. Natl. Acad. Sci. U.S.A., 101, 12604, 10.1073/pnas.0405077101 Callicott, 2005, Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia, Proc. Natl. Acad. Sci. U.S.A., 102, 8627, 10.1073/pnas.0500515102 Esslinger, 2009, Neural mechanisms of a genome-wide supported psychosis variant, Science, 324, 605, 10.1126/science.1167768 Bigos, 2010, Genetic variation in CACNA1C affects brain circuitries related to mental illness, Arch. Gen. Psychiatry, 67, 939, 10.1001/archgenpsychiatry.2010.96 Insel, 2010, Research domain criteria (RDoC): toward a new classification framework for research on mental disorders, Am. J. Psychiatry, 167, 748, 10.1176/appi.ajp.2010.09091379 Manolio, 2010, Genomewide association studies and assessment of the risk of disease, N. Engl. J. Med., 363, 166, 10.1056/NEJMra0905980 Wang, 2010, Analysing biological pathways in genome-wide association studies, Nat. Rev. Genet., 11, 843, 10.1038/nrg2884 Mooney, 2014, Functional and genomic context in pathway analysis of GWAS data, Trends Genet., 30, 390, 10.1016/j.tig.2014.07.004 Heck, 2014, Converging genetic and functional brain imaging evidence links neuronal excitability to working memory, psychiatric disease, and brain activity, Neuron, 81, 1203, 10.1016/j.neuron.2014.01.010 Voineagu, 2011, Transcriptomic analysis of autistic brain reveals convergent molecular pathology, Nature, 474, 380, 10.1038/nature10110 Holmans, 2009, Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder, Am. J. Hum. Genet., 85, 13, 10.1016/j.ajhg.2009.05.011 Stergiakouli, 2012, Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD, Am. J. Psychiatry, 169, 186, 10.1176/appi.ajp.2011.11040551 O’Dushlaine, 2011, Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility, Mol. Psychiatry, 16, 286, 10.1038/mp.2010.7 Gaudet, 2010, Common genetic variants and modification of penetrance of BRCA2-associated breast cancer, PLoS Genet., 6, e1001183, 10.1371/journal.pgen.1001183 Okada, 2014, Genetics of rheumatoid arthritis contributes to biology and drug discovery, Nature, 506, 376, 10.1038/nature12873 Kathiresan, 2008, Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans, Nat. Genet., 40, 189, 10.1038/ng.75 Burkhardt, 2008, Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13, Arterioscler. Thromb. Vasc. Biol., 28, 2078, 10.1161/ATVBAHA.108.172288 Altshuler, 2000, The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes, Nat. Genet., 26, 76, 10.1038/79216